China BCT's Form S-1 Registration Statement Declared Effective

LIUZHOU CITY, China, March 18, 2011 /PRNewswire-Asia/ -- China BCT Pharmacy Group, Inc., (OTC Bulletin Board: CNBI), ("China BCT" or the "Company"), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced that its Form S-1 registration statement filed with the Securities and Exchange Commission ("SEC") was declared effective on March 17, 2011. Pursuant to the statement, a total of 5,630,575 shares have been registered with the SEC, representing approximately 13.98% of the Company's fully diluted shares outstanding as of February 28, 2011. The prospectus contained in the Form S-1 relates to the resale of shares issued to those stockholders who participated in previously completed private placement transactions which were exempt from the registration and prospectus delivery requirements of the Securities Act of 1933, as amended.